Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge

Tuberculosis (TB) vaccine development has focused largely on targeting T helper type 1 (Th1) cells. However, despite inducing Th1 cells, the recombinant TB vaccine MVA85A failed to enhance protection against TB disease in humans. In recent years, Th17 cells have emerged as key players in vaccine-ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Monin, Leticia, Griffiths, Kristin, Slight, Samantha, Lin, Yin-yao, Rangel-Moreno, Javier, Khader, Shabaana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517980/
https://www.ncbi.nlm.nih.gov/pubmed/25627812
http://dx.doi.org/10.1038/mi.2014.136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517980/
https://www.ncbi.nlm.nih.gov/pubmed/25627812
http://dx.doi.org/10.1038/mi.2014.136

Ejemplares similares